相关实验视频

Updated: May 15, 2025

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

多发性骨髓瘤的治疗目标发现:通过孟德尔随机化识别可用药物的基因

Shijun Jiang¹, Fengjuan Fan¹, Qun Li¹

¹Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

|April 29, 2025

概括

这项研究确定了Orosomucoid 1 (ORM1) 和Oviductal Glycoprotein 1 (OVGP1) 作为多发性骨髓瘤 (MM) 的新型治疗点. 孕醇和氨基酸在抑制MM细胞生长方面表现有前途,提供了新的治疗策略.

科学领域:

遗传学遗传学是一个
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

多发性髓瘤 (MM) 是一种骨髓恶性瘤,在复发和耐药性方面存在重大挑战.
新的治疗目标对于改善MM治疗结果至关重要.

研究的目的:

通过使用孟德尔随机化 (MR) 来识别多发性骨髓瘤 (MM) 的新药可用基因.
为了验证潜在的治疗药物针对MM治疗的鉴定基因.

主要方法:

门德尔随机化 (MR) 分析以确定因果基因.
为了验证,进行了全转录组关联研究 (TWAS) 和同位化分析.
MR-PheWAS用于非目标效应,分子对接和药物有效性的功能测试.

主要成果:

通过MR识别了9个可用药物的基因,其中ORM1和OVGP1从TWAS和局部化中显示出强有力的证据.
在MM细胞中,ORM1和OVGP1的下调显著.
孕醇 (ORM1激动剂) 和阴素 (OVGP1激动剂) 抑制了MM细胞活力,并上调了基因表达.

结论:

ORM1和OVGP1代表了多发性骨髓瘤的新型治疗点.
普雷格涅诺和伊利诺特干显示出在MM治疗中临床应用的潜力.
这些发现提供了对MM病原体和克服药物耐药性的策略的见解.

关键词:

这就是ORM1的ORM1.在 OVGP1 中使用.这种药物是氨酸 (irinotecan) 的.门德尔的随机化是门德尔的随机化多发性骨髓瘤是多发性骨髓瘤的一种.孕产妇的孕产妇的孕产妇

更多相关视频

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...